Moleculin Announces Positive Interim Results in First Cohort of Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia in the US and in Poland

Stock Information for Moleculin Biotech Inc.

Loading

Please wait while we load your information from QuoteMedia.